<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00507104</url>
  </required_header>
  <id_info>
    <org_study_id>pitfunction_TBI_SAH</org_study_id>
    <nct_id>NCT00507104</nct_id>
  </id_info>
  <brief_title>Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)</brief_title>
  <official_title>Prospective Longitudinal Study on Pituitary Functions After TBI and/or SAH</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study performs assessments of pituitary functions by basal hormone levels in the acute&#xD;
      phase after TBI and/or SAH followed by detailed endocrine tests (insulin-induced hypoglycemia&#xD;
      or growth hormone releasing hormone-arginine-corticotropin releasing hormone-leuteinizing&#xD;
      hormone releasing hormone [GHRH-arginine-CRH-LHRH] test) after 4 and 12 months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent data have demonstrated that hypopituitarism seems to be a frequent finding after&#xD;
      traumatic brain injury (TBI) and/or subarachnoid hemorrhage (SAH). However, most of these&#xD;
      studies referred to retrospective evaluations. There are only few prospective data, and no&#xD;
      longitudinal study routinely taking into account the assessment of anterior pituitary&#xD;
      function in the acute phase after TBI or SAH so far.&#xD;
&#xD;
      We prospectively evaluate pituitary functions in patients in the acute phase after TBI or SAH&#xD;
      and a control group of patients with trauma not involving the brain. Endocrine data included&#xD;
      basal anterior pituitary lobe hormone, IGF-1 and testosterone serum levels (Immulite 2000)&#xD;
      within the first 8 hours after TBI or SAH. Further endocrine evaluation was performed by&#xD;
      means of either a combined GHRH-arginine-CRH-LHRH test or an insulin-induced hypoglycemia&#xD;
      test after 4 months and 12 months. To rule out an assay related bias with regard to GH and&#xD;
      IGF-1, all hormone levels were cross-checked by a supersensitive assay in another laboratory.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2006</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">100</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <condition>Subarachnoid Hemorrhage</condition>
  <condition>Hypopituitarism</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  TBI or SAH&#xD;
&#xD;
          -  Control group: injury without involvement of the brain/skull&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Buchfelder, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Neurosurgery, University of Erlangen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juergen Kreutzer, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurosurgery, University of Erlangen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christioph Schöfl, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurosurgery, Division Neuroendocrinology, University of Erlangen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Kleindienst, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurosurgery, University of Erlangen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurosurgery, University of Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>July 24, 2007</study_first_submitted>
  <study_first_submitted_qc>July 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2007</study_first_posted>
  <last_update_submitted>December 10, 2020</last_update_submitted>
  <last_update_submitted_qc>December 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>traumatic brain injury</keyword>
  <keyword>Subarachnoid Hemorrhage</keyword>
  <keyword>Hypopituitarism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Hypopituitarism</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

